Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05967260 · ClinicalTrials.gov registry record · NA
DailyDose Smart Snack Study for T1D on MDI
A NA study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT05967260 is a NA study that has completed, run by Oregon Health and Science University. The registered enrollment target is 21 participants.
The verdict
NCT05967260, a NA study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
This is a single-center, open-label, crossover trial with two arms and two periods (2x2) and one-week washout period. The study is designed to evaluate the efficacy of an AI-based bedtime smart snack intervention in reducing nocturnal low glucose in people living with T1D on MDI therapy compared with traditional CGM-augmented MDI therapy as the control.
Interventions
- DEVICE Dexcom G6 CGM
- DEVICE DailyDose Smart Snack app
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2023-09-01 |
| Est. Completion | 2024-09-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05967260
The ClinicalTrials.gov registry entry for NCT05967260 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dexcom G6 CGM is the first listed.
NCT05967260 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05967260 about?
NCT05967260 is a clinical study titled "DailyDose Smart Snack Study for T1D on MDI". This is a single-center, open-label, crossover trial with two arms and two periods (2x2) and one-week washout period. The study is designed to evaluate the efficacy of an AI-based bedtime smart snack intervention in reducing nocturnal low glucose in people living with T1D on MDI therapy compared wit...
What is the current status of trial NCT05967260?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2023-09-01. Estimated completion is 2024-09-20.
What interventions are being tested in trial NCT05967260?
The interventions under investigation include: Dexcom G6 CGM (DEVICE), DailyDose Smart Snack app (DEVICE).
Who is sponsoring clinical trial NCT05967260?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.